IL6 and neoplasm: Tumor burden caused a marked increase in the serum IL-6 level (p = 0.0008), and the administration of WCUP significantly decreased the IL-6 level in the serum of CT-26 tumor-bearing mice in a dose-dependent manner (F = 27.73, p = 0.0009) (Fig. 3A).